EXHIBIT - NO. - 99.1
FROM: FOR:
Swenson/Falker Associates Inc. CNS, Inc.
1111 TCF Tower, 121 S. 8th Street 4400 W. 78th Street
Minneapolis, Minn. 55402 Bloomington, Minn. 55435
Contact-Curt Swenson 612/371-0000 Contact-Richard E. Jahnke or
Daniel E. Cohen 612/820-6696
And:
LecTech Corporation
FOR IMMEDIATE RELEASE 10701 Red Circle Dr.
Minnetonka, MN 55343
Contact-Erwin Templin 612/933-2291
CNS AND LECTEC ANNOUNCE DEFINITIVE AGREEMENT
ON MARKETING ALLIANCE FOR ANALGESIC PAIN PATCH
- ----------------------------------------------
MINNEAPOLIS, Jan. 11 -- CNS, Inc., (NASDAQ/NM:CNXS) and LecTec
Corporation (NASDAQ/NM:LECT) have executed a definitive agreement under which
CNS will private-label and market LecTec's analgesic pain patch as a
non-prescription product to consumers in the U.S. and Canada, the companies
announced today.
The patch, which delivers analgesics to the skin, will be marketed for
external application for temporary relief of pain from arthritis, simple
backache and muscular aches and strains. It is an alternative to topical
analgesic rubs and various pain-relief pills and has been cleared for
marketing by the U.S. Food and Drug Administration.
Test marketing is planned to begin during the first half of this year, to
be followed by a national product roll-out.
CNS, based in Minneapolis, designs, manufacturers and markets consumer
products, including the Breathe Right} nasal strip which improves breathing by
reducing nasal airflow resistance.
LecTec, also based in Minneapolis, develops, manufactures and markets
medical products, including diagnostic and monitoring electrodes, conductive
hydrogels, medical tape and a growing range of therapeutic products.
# # # #
01/11/96